Cargando…
Estimating Inhaled Corticosteroid Exposure from Short-Acting β(2)-Agonist–Inhaled Corticosteroid Rescue
Autores principales: | Lugogo, Njira, Gilbert, Ileen, Pollack, Michael, Gandhi, Hitesh, Tkacz, Joseph, Lanz, Miguel J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239732/ https://www.ncbi.nlm.nih.gov/pubmed/37284334 http://dx.doi.org/10.2147/JAA.S408504 |
Ejemplares similares
-
Demographics, Treatment Patterns, and Morbidity in Patients with Exercise-Induced Bronchoconstriction: An Administrative Claims Data Analysis
por: Lanz, Miguel J, et al.
Publicado: (2021) -
Inhaled Corticosteroids
por: Barnes, Peter J.
Publicado: (2010) -
Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting β(2)-agonist via dry-powder inhalers and pressurized metered-dose inhalers
por: Wittbrodt, Eric T, et al.
Publicado: (2018) -
An assessment of asthma exacerbations in pediatric patients using a long-acting B2-agonist plus inhaled corticosteroid versus an inhaled corticosteroid alone
por: Alakeel, Yousif S., et al.
Publicado: (2022) -
Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
por: Rottenkolber, Marietta, et al.
Publicado: (2015)